Covance

Aptuit names Paul Overton EVP, business development & marketing

Tuesday, July 22, 2014 08:00 AM

Aptuit, a provider of integrated early to mid-phase drug development services, has appointed Paul D. Overton, Ph.D., executive vice president, business development and marketing, making him responsible for all of Aptuit's sales and marketing activities.

More... »

WIRB Copernicus Group

Covance adds two to clinical development services leadership team

Monday, July 14, 2014 01:04 PM

Covance has announced two key additions to its clinical development services scientific leadership team with the appointments of Robert Wasserman, M.D., as vice president and global therapeutic area head, oncology, and Rogelio Mosqueda-Garcia, M.D., Ph.D., as global vice president, early clinical services within medical and scientific affairs. Both are based in Princeton, N.J.

More... »


Covance launches MarketPlace for biopharmaceutical development

Monday, June 23, 2014 01:36 PM

CRO Covance has introduced Covance MarketPlace, a new solution that enables Covance’s emerging biotechnology and established pharmaceutical clients to easily find and forge new partnerships in a secure forum.

More... »

Discovery Labs adds to scientific leadership team

Friday, May 23, 2014 12:23 PM

Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, has strengthened its scientific leadership. Effective immediately, Steve Simonson, M.D., M.H.S., has joined the company as vice president, Clinical Development, and Lawrence Weinstein has joined as vice president, Medical Device Development.

More... »

Covance acquires Medaxial

Monday, May 19, 2014 01:29 PM

CRO Covance has acquired Medaxial, a London-based value communication consultancy. The company specializes in an integrated approach to market access strategy, health economic modeling and data dissemination services, and focuses on defining and communicating the value of a biopharmaceutical product or medical device to healthcare payers and the stakeholders who influence them.

More... »

Covance expands global biologics capabilities

Monday, March 31, 2014 01:36 PM

Covance is expanding its global bioanalytical footprint and adding scientific leaders to its biologics team. It is expanding its large-molecule bioanalytical space co-located with its central laboratory facility in Indianapolis.

More... »

Report: pharmacovigilance market, service providers to reach $5B globally in 2019

Friday, February 28, 2014 12:02 PM

According to a new market report published by Transparency Market Research, the global pharmacovigilance market was valued at $2,147.3 million in 2012 and is estimated to reach a market worth $5,008.2 million in 2019, at a CAGR of 12.9% from 2013 to 2019.

More... »

Covance to open nutritional chemistry lab in England

Friday, January 24, 2014 11:48 AM

Princeton, New Jersey-based CRO Covance has announced the expansion of its nutritional chemistry and food safety services, opening a 10,000-square-foot laboratory this summer within its existing facility in Harrogate, England. This new lab will complement existing labs in Madison, Wis.; Battle Creek, Mich.; Greenfield, Ind.; and Singapore, and will help Covance continue to promote food safety and nutritional health on a global scale.

More... »

DaVita Clinical Research collaborates with Pacific Pharma Group

Monday, January 6, 2014 11:57 AM

DaVita Clinical Research (DCR), a specialty CRO with services in drug and device development, has formed a non-exclusive agreement with Pacific Pharma Group to provide consulting, program strategy and protocol design support for clinical pharmacology studies performed at DCR.

More... »

Joseph L. Herring, Neil M. Kurtz elected to Team Health Holdings board of directors

Tuesday, November 26, 2013 11:00 AM

Team Health Holdings, a provider of outsourced physician staffing solutions for hospitals, has announced that Joseph L. Herring and Neil M. Kurtz, M.D., were elected to the company's board of directors. As chairman of the board and CEO of Covance, Herring leads one of the largest public CROs in the world, managing $2.5 billion in revenue and 12,000 employees in 65 countries. As president and CEO of Golden Living, a privately-held skilled nursing, hospice, home healthcare and institutional pharmacy company with more than 300 locations nationwide, Kurtz leads the largest company of its kind in the industry, managing approximately $3 billion in revenue and 43,000 employees.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs